Skip to content
Search

Latest Stories

Sushant Singh Rajput to topline Rifleman

Bollywood star Sushant Singh Rajput, who is on cloud nine after the success of his recent release Kedarnath (2018), has announced his next film. Titled Rifleman, the movie tells the story of an Indian soldier played by the actor.

Sushant Singh Rajput announced his new project yesterday, on the occasion of 71st Army Day. Apart from announcing the project, he also unveiled the first motion poster of the movie.


The actor shared the motion poster on Instagram and captioned it as, “An advancing enemy. A border to protect. One Braveheart. RIFLEMAN. On the occasion of Army Day, excited to announce my next film. @indianarmy.adgpi The film is produced by @abundantiaent & @pooja_ent."

After sharing the poster on Instagram, Sushant also took to micro-blogging site Twitter and shared the same poster.

Rifleman is jointly produced by Abundantia Entertainment and Pooja Films. It is scheduled for a release this year.

Meanwhile, Sushant Singh Rajput is presently shooting for Nitesh Tiwari’s next directorial venture, Chhichhore. The film stars Shraddha Kapoor as the female lead.

More For You

TV doctor Punam Krishan says she is ‘healing’ after breast cancer treatment

She urged people to know their bodies, trust themselves and seek medical advice early

Getty Images

TV doctor Punam Krishan says she is ‘healing’ after breast cancer treatment

Highlights

  • Morning Live doctor says she was diagnosed five months ago
  • Treatment is complete, but she says the experience has left her shaken
  • Krishan urges people to trust their instincts and act early
  • The NHS GP praised staff who cared for her during treatment

Diagnosis kept private during treatment

TV doctor Punam Krishan has revealed she was diagnosed with breast cancer five months ago and has now completed her treatment.

The Glasgow-born GP, 42, shared the news in an Instagram post alongside a photo of herself in a hospital bed, saying she is now healing but remains emotionally shaken by the experience.

Keep ReadingShow less